Literature DB >> 30307552

Impact of the duration of antibiotic therapy on relapse and survival following surgery for active infective endocarditis.

Vinay P Rao1, Jianhua Wu2, Richard Gillott1, M Wazir Baig1,2, Pankaj Kaul1,2, Jonathan A T Sandoe1,2.   

Abstract

OBJECTIVES: Surgery is often required for acute infective endocarditis (IE) to repair or replace damaged heart valves. Traditionally, long courses of antibiotic treatment have been prescribed after surgery for active IE for fear of infecting newly implanted/repaired valves, but the need for this, in the present era of enhanced antimicrobial stewardship, has been questioned. In our institution, the choice and duration of antimicrobial therapy is tailored to individual patients by a multidisciplinary team with an interest in IE. The influence of the duration of postoperative antibiotic therapy on outcomes was studied in patients requiring surgery prior to the completion of a planned course of antibiotic therapy.
METHODS: This was a retrospective observational study on patients with acute IE requiring surgery between January 2004 and December 2015. The primary outcome was relapse. Secondary outcomes were early reoperation and 1-year mortality.
RESULTS: In total, 182 IE episodes were included in the final analysis. The median duration of postoperative antibiotic therapy was 23.5 days (interquartile range 12-40 days) and decreased significantly during the period of study (P < 0.001). There were 2 relapses (1.1%) and 18 (9.9%) postoperative deaths within 1 year. Nine (5%) patients underwent early reoperation. The duration of postoperative antibiotic therapy did not affect either the primary or the secondary outcomes.
CONCLUSIONS: This work supports previous findings that selected patients who require surgery during active IE can be safely given shorter courses of postoperative antibiotics without an impact on relapse of infection or survival.
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Infective endocarditis; Outcome; Relapse of infection; Valve replacement

Year:  2019        PMID: 30307552     DOI: 10.1093/ejcts/ezy325

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Infective Endocarditis Guidelines: The Challenges of Adherence-A Survey of Infectious Diseases Clinicians.

Authors:  Glen Huang; Siddhi Gupta; Kyle A Davis; Erin W Barnes; Susan E Beekmann; Philip M Polgreen; James E Peacock
Journal:  Open Forum Infect Dis       Date:  2020-08-24       Impact factor: 3.835

2.  Impact of Valve Culture Positivity on Prognosis in Patients with Infective Endocarditis Who Underwent Valve Surgery.

Authors:  Jinnam Kim; Jung Ho Kim; Hi Jae Lee; Se Ju Lee; Ki Hyun Lee; Eun Hwa Lee; Yae Jee Baek; Jin Young Ahn; Su Jin Jeong; Nam Su Ku; Seung Hyun Lee; Jun Yong Choi; Joon-Sup Yeom
Journal:  Infect Dis Ther       Date:  2022-04-30

3.  Reduced Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in Cardiac Surgery Patients after Implementation of an Antimicrobial Stewardship Project.

Authors:  Daniele Roberto Giacobbe; Antonio Salsano; Filippo Del Puente; Francesco Campanini; Giovanni Mariscalco; Anna Marchese; Claudio Viscoli; Francesco Santini
Journal:  Antibiotics (Basel)       Date:  2019-08-28

4.  Partial oral antibiotic treatment of endocarditis in patients who inject drugs: a case series.

Authors:  Kaylie Miller; Emily Evans; Kathleen R Sheridan; Varidhi Nauriyal; J Alexander Viehman; Ryan Rivosecchi; Bobbi Jo Stoner; Sami El-Dalati
Journal:  JAC Antimicrob Resist       Date:  2022-02-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.